Pulmonary function tests (PFTs) are crucial tools in diagnosing and monitoring respiratory conditions. However, interpreting these results can be complex.
Key parameters include Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), and their ratio. FVC indicates lung capacity while FEV1 reflects airflow obstruction. A low FEV1/FVC ratio suggests obstructive lung disease.
Spirometry can reveal obstructive patterns (e.g., asthma, COPD) or restrictive patterns (e.g., fibrosis). Obstructive disorders show reduced FEV1 with normal or increased FVC, while restrictive disorders display reduced FVC with normal or increased FEV1.
Diffusion capacity for carbon monoxide (DLCO) reflects gas exchange efficiency. Reduced DLCO may indicate interstitial lung disease or pulmonary vascular disorders.
Understanding PFTs is pivotal for accurate diagnosis and treatment of respiratory diseases. Continual education in PFT interpretation enhances patient care and outcomes.
1.
NPM1-Mutated AML: Not All Treatments Are Equal
2.
Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey
3.
MRI can save rectal cancer patients from surgery, study suggests
4.
Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer
5.
Rising rates of head and neck cancers in England
1.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
2.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
3.
Molecular Classification of Refractory Anemia: A Comprehensive Review
4.
Ferroptosis-Modulating Therapeutics in Precision Oncology
5.
Blood-Cell Morphology Foundation Models: Transforming Hematological Diagnostics and Clinical Practice
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Thromboprophylaxis In Medical Settings- An Update
3.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
4.
How Platelet Disorders Can Affect the Body
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation